Influence of adenosine receptor A2a antagonist on glutamate transporter GLT-1 expression in middle cerebral artery ischemia-reperfusion injury zone of rats
|更新时间:2025-01-15
|
Influence of adenosine receptor A2a antagonist on glutamate transporter GLT-1 expression in middle cerebral artery ischemia-reperfusion injury zone of rats
Journal of Army Medical UniversityVol. 33, Issue 8, Pages: 785-788(2011)
作者机构:
第三军医大学西南医院神经内科
作者简介:
基金信息:
DOI:
CLC:R741.02;R971;R743.31
Published:2011,
Published Online:30 April 2011,
稿件说明:
移动端阅览
LIU BIN, CHEN KANGNING, WANG HAOXIANG, et al. Influence of adenosine receptor A2a antagonist on glutamate transporter GLT-1 expression in middle cerebral artery ischemia-reperfusion injury zone of rats. [J]. Journal of army medical university, 2011, 33(8): 785-788.
DOI:
LIU BIN, CHEN KANGNING, WANG HAOXIANG, et al. Influence of adenosine receptor A2a antagonist on glutamate transporter GLT-1 expression in middle cerebral artery ischemia-reperfusion injury zone of rats. [J]. Journal of army medical university, 2011, 33(8): 785-788.DOI:
Influence of adenosine receptor A2a antagonist on glutamate transporter GLT-1 expression in middle cerebral artery ischemia-reperfusion injury zone of rats
Objective To observe the influence of adenosine receptor A2a antagonist on the glutamate transporter GLT-1 expression in the corpus striatum of rat middle cerebral artery occlusion (MCAO) models
and investigate its mechanism of ischemic neuroprotection. Methods Two models of male SD rats
one suffering 2 h of cerebral ischemia and the other suffering 2 h of cerebral ischemia followed by 22 h of reperfusion
were constructed. Each model was divided in a sham operation group
an ischemia control group
and an intervention group. Adenosine receptor A2a antagonist SCH-58261 was administered to the sham operation groups and the intervention groups. The expression of GLT-1 in the corpus striatum was detected by RT-PCR and Western blotting. The cerebral infarction volume and the neurological deficit condition were also observed. Results There was no significant difference between the neurological deficit scores of the control group and the intervention group in the cerebral ischemia (2 h) model. There was a significant difference between the neurological deficit scores of the control group (2.50±0.55) and the intervention group (1.67±0.52) in the cerebral ischemia (2 h)-reperfusion (22 h) model (
P
<
0.05). The cerebral infarction volume (23.63±3.89) of the intervention group in the cerebral ischemia (2 h) model was decreased by 16% (
P
<
0.05) as compared to that of the control group. The cerebral infarction volume (95.12±18.22) of the intervention group in the cerebral ischemia (2 h)-reperfusion (22 h) model was decreased by 33% (
P
<
0.01) as compared to that of the control group. After SCH-58261 administration
the expression of GLT-1 in the corpus striatum of rat MCAO models during the acute ischemia stage and the ischemia-reperfusion stage was increased significantly. Conclusion The neuroprotection of adenosine receptor A2a antagonist against cerebral ischemia is correlated with the enhancement of GLT-1 function.